![]() |
|
|
Vol. 290, Issue 3, 1258-1269, September 1999
Pharmaceutical Research and Development Division, Recordati
S.p.A., Milan, Italy
Several novel N-arylpiperazine derivatives
were synthesized and tested for their 1) affinity and functional
activity on 5-hydroxytryptamine1A (5-HT1A)
receptors in vitro; 2) activity in models predictive of antagonism at
somatodendritic and postsynaptic 5-HT1A receptors; and 3)
effects on the micturition reflex in anesthetized and conscious rats.
These studies also included
1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl] piperazine
hydrobromide (NAN 190),
8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4,5]decane-7,9-dione dihydrochloride (BMY 7378), and
N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-(2-pyridinyl)cyclohexanecarboxamide (WAY 100635). Almost all compounds were found to be potent and selective for the human recombinant 5-HT1A receptor, with
Ki values in the nanomolar range.
[35S]GTP
S binding in HeLa cells expressing the
recombinant human 5-HT1A receptor allowed classification of
the compounds into neutral antagonists and partial agonists. Almost all
neutral antagonists were active in blocking
8-hydroxy-2-dipropylaminotetralin (8-OH-DPAT)-induced forepaw treading
in rats (postsynaptic model) and hypothermia in mice (somatodendritic
model) with the same potency, whereas compounds showing partial
agonistic activity were active in the postsynaptic model but were
inactive, or poorly active, in the somatodendritic model. Neutral
antagonists potently inhibited volume-induced bladder-voiding
contractions in anesthetized rats. Contractions were completely
blocked, and the disappearance of bladder contractions lasted 7 to 13 min after the highest doses tested. Furthermore, neutral antagonists
increased bladder volume capacity in conscious rats during
continuous transvesical cystometry, whereas micturition pressure was
only slightly, and not dose-dependently, reduced. Partial agonists were
inactive or poorly active, inducing a disappearance time of bladder
contractions that did not exceed 6 min in anesthetized rats, and
failing to increase bladder volume capacity in conscious rats. These
findings indicate that only neutral 5-HT1A receptor
antagonists are endowed with inhibitory effects on the bladder.
This article has been cited by other articles:
![]() |
S.-F. Pan, H.-Y. Peng, C.-C. Chen, M.-J. Chen, S.-D. Lee, C.-L. Cheng, J.-C. Shyu, J.-M. Liao, G.-D. Chen, and T.-B. Lin Nicotine-activated descending facilitation on spinal NMDA-dependent reflex potentiation from pontine tegmentum in rats Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1195 - F1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-D. Chen, H.-Y. Peng, K.-C. Tung, C.-L. Cheng, Y.-J. Chen, J.-M. Liao, Y.-C. Ho, S.-F. Pan, M.-J. Chen, and T.-B. Lin Descending facilitation of spinal NMDA-dependent reflex potentiation from pontine tegmentum in rats Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1115 - F1122. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Erschbamer, K. Pernold, and L. Olson Inhibiting Epidermal Growth Factor Receptor Improves Structural, Locomotor, Sensory, and Bladder Recovery from Experimental Spinal Cord Injury J. Neurosci., June 13, 2007; 27(24): 6428 - 6435. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Dolber, B. Gu, X. Zhang, M. O. Fraser, K. B. Thor, and J. P. Reiter Activation of the external urethral sphincter central pattern generator by a 5-HT1A receptor agonist in rats with chronic spinal cord injury Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1699 - R1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Chang, C.-L. Cheng, J.-J. J. Chen, and W. C. de Groat Serotonergic drugs and spinal cord transections indicate that different spinal circuits are involved in external urethral sphincter activity in rats Am J Physiol Renal Physiol, March 1, 2007; 292(3): F1044 - F1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Chang, C.-L. Cheng, J.-J. J. Chen, and W. C. de Groat Roles of glutamatergic and serotonergic mechanisms in reflex control of the external urethral sphincter in urethane-anesthetized female rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2006; 291(1): R224 - R234. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Corradetti, B. Mlinar, C. Falsini, A. M. Pugliese, A. Cilia, C. Destefani, and R. Testa Differential Effects of the 5-Hydroxytryptamine (5-HT)1A Receptor Inverse Agonists Rec 27/0224 and Rec 27/0074 on Electrophysiological Responses to 5-HT1A Receptor Activation in Rat Dorsal Raphe Nucleus and Hippocampus in Vitro J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 109 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-E. Andersson and A. J. Wein Pharmacology of the Lower Urinary Tract: Basis for Current and Future Treatments of Urinary Incontinence Pharmacol. Rev., December 1, 2004; 56(4): 581 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Leonardi, L. Guarneri, E. Poggesi, P. Angelico, C. Velasco, A. Cilia, and R. Testa N-[2-[4-(2-Methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) Cyclohexanecarboxamide: A Novel Pre- and Postsynaptic 5-Hydroxytryptamine1A Receptor Antagonist Active on the Lower Urinary Tract J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1027 - 1037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Miura, M. Kawatani, and W. C. de Groat Excitatory Synaptic Currents in Lumbosacral Parasympathetic Preganglionic Neurons Elicited From the Lateral Funiculus J Neurophysiol, October 1, 2001; 86(4): 1587 - 1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kakizaki, M. Yoshiyama, T. Koyanagi, and W. C. De Groat Effects of WAY100635, a selective 5-HT1A-receptor antagonist on the micturition-reflex pathway in the rat Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1407 - R1413. [Abstract] [Full Text] [PDF] |
||||